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HYDROGEL IMPLANT WITH SUPERFICIAL 
PORES 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation of U.S. patent applica-
tion Ser. No. 11/053,409, filed Feb. 7, 2005, which claims the 
benefit of U.S. Provisional Patent Application Ser. No. 
60/542,389, filed Feb. 6, 2004, both of which are incorporated 
by reference herein in their entireties. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The invention relates to spinal disc replacement devices, 
particularly devices which mimic native spinal discs, for 
implantation which is compatible with living tissue. The 
invention also relates to implants suitable for load-bearing 
surfaces in the repair of tissue, replacement or augmentation, 
and methods of using such. One embodiment of the invention 
relates to an implantable spinal disc prosthesis. 
2. Background Art 
Materials used in the construction of implantable medical 
devices must be nontoxic, nonantigenic, and noninflamma-
tory. Hydrogels are a preferred type of polymeric material for 
implantable devices. Because of their high water content, 
analogous to living tissue, they are superior in biocompatibil-
ity to non-hydrous polymeric materials. 
U.S. Pat. No. 5,981,826, issued to Ku et al., describes the 
preparation of polyvinyl alcohol hydrogels (PVA-H) by 
physically crosslinking an aqueous solution of polyvinyl 
alcohol (PVA) to produce a gel. The crosslinking is accom-
plished by subjecting the aqueous PVA solution to multiple 
cycles of freezing and thawing. One limitation of the prior art 
is that the hydrogels produced are relatively nonporous and 
the pore size and degree of porosity, that is the density of the 
pores within the hydrogel, cannot vary independently of the 
mechanical properties or stiffness of the hydrogel. 
Methods for producing certain porous hydrogels also exist 
in the art. U.S. Pat. No. 6,268,405, issued to Yao et al., 
describes methods for creating porous PVA-Hs by including 
immiscible materials in the polymerization process. After the 
hydrogel is polymerized, the included immiscible materials 
are washed out of the hydrogel by an appropriate solvent, 
yielding pores which are broadly distributed throughout the 
hydrogel. Controlling the size and density of the pores is 
accomplished by varying the molecular weight of the immis-
cible materials. A disadvantage ofYao et al. is that the range 
of attainable pore sizes is limited. Moreover, the invention of 
Yao et al. is limited in that it can only produce hydrogels 
whose pores extend throughout the hydrogel. The pores in 
Yao et al. are intended to create vascularization of the hydro-
gel in soft or non-load bearing tissue. A further disadvantage 
ofYao et al. is that the pore sizes are broadly distributed about 
the average pore size. 
Artificial discs intended for the replacement of a damaged 
intravertebral disc have been described. These are typically 
articulated devices comprising two rigid metal plates adhered 
2 
Pat. No. 6,482,234, issued to Weber et al., include descrip-
tions of elastomeric cores that may be formed from materials 
with different elasticities to better mimic the native structure 
of spinal discs. 
Artificial discs have also been described wherein the disc is 
comprised of a flexible urethane silicone blend core and two 
identical rigid surfaces on either side of the core. U.S. Pat. No. 
6,607,558 to Kuras describes such a disc where nail like 
projections extend from the surface to fixate the disc between 
10 the vertebrae. Such a disc also possesses a different material 
for the end plates as for the elastic core. 
The disadvantage of the artificial disc devices of the prior 
art are numerous. These prior art devices require the mechani-
cal attachment of rigid artificial materials, such as titanium, 
15 directly to the bone with screws, staples, nails, cement, or 
other mechanical means. These rigid materials are only mini-
mally compatible with natural, living bone and separation of 
the implant from the bone is often observed over long-term 
implantation. In addition, materials used in artificial discs of 
20 the prior art have physical and mechanical properties dis-
tinctly different from those of natural spinal discs and thus 
inadequately duplicate the desired properties of native spinal 
discs. 
Vertebral fusion is still the most commonly performed 
25 procedure to treat debilitating pain associated with degenera-
tive spinal disc disease or disc trauma, despite the fact that the 
procedure has many drawbacks. Vertebral fusion increases 
stress and strain on the discs adjacent to the fusion site, and it 
is now widely accepted that fusion is responsible for the 
30 accelerated degeneration of adjacent levels. Current multi-
component spinal disc prosthesis designs, elastomeric cores 
with metal plates on both the upper and lower surfaces, are 
susceptible to problems with interfacial bonding and wear. 
These designs have shown spontaneous device detachment 
35 due to retraction of bone tissue from the metal surface. 
Bone ingrowth and attachment in the art has often required 
the use of bone promoting growth factors. For example, U.S. 
Pat. No. 5,108,436, issued to Chu et al., describes using a 
porous implant for use in load bearing bone replacement 
40 which is used in combination with an osteogenic factor such 
as TGF-~. 
Biomedical devices which are implanted in or around bone 
often fail because of fibrinogen encapsulation of the implant 
instead of cellular attachment to the implant itself. This 
45 encapsulation is a defensive reaction attempting to minimize 
contact between the body and the implant and is considered a 
sign of implant incompatibility. 
Moreover, the art of bone ingrowth onto implantable sur-
face contains a multitude of examples relating to porous 
50 directed ingrowth where bone essentially grows into and 
around channels of the implant. For example, U.S. Pat. No. 
4,911,720, issued to Collier et al., discusses the ingrowth of 
bone into interconnecting pores which essentially locks bone 
into place. This method is disadvantageous in that bone does 
55 not actually attach itself to the material, instead bone attaches 
to other bone around the implant. In the unfortunate event that 
an implant must be removed, this type of Collier ingrowth 
results in large amounts of disruption to the surrounding bone 
tissue. 
to opposite ends of an elastomeric core. In use, the artificial 60 
disc is placed in the intervertebral space and the metal plates 
are secured to the surfaces of adjacent vertebrae. Various 
embodiments of artificial discs of this type are described in 
U.S. Pat. Nos. 5,674,296 and 6,156,067, issued to Bryan et 
al., U.S. Pat. No. 5,824,094, issued to Serhan et al., U.S. Pat. 65 
No. 6,402,785, issued to Zdeblick et al. More recent embodi-
ments, e.g. U.S. Pat. No. 6,419,704, issued to Ferree and U.S. 
SUMMARY OF THE INVENTION 
The present invention describes a hydrogel for implanta-
tion into a load bearing space within the body. The hydrogel 
has a textured surface on it which is comprised of superficial 
surface pores. Stated differently, the pores on the surface of 
the hydro gel substrate do not extend throughout the hydrogel 
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but instead remain within a region near the surface. The pores The present invention also includes a method for making a 
hydrogel substrate comprising contacting solid objects with 
an aqueous hydrogel, allowing the hydrogel to polymerize 
and crosslink while the solid objects are at least partially 
immersed in the hydrogel, and removing those solid objects 
from the polymerized and crosslinked hydrogel to form 
superficial pores thereon. The solid objects used to impart the 
superficial pores may be polystyrene beads. Alternatively, the 
solid objects used to impart the superficial pores may be grit, 
on this hydrogel substrate can have an average diameter of 
between 1 and 100 micrometers. Preferably the average 
diameter of surface pores on the hydrogel substrate is 
between 5 and 50 micrometers, and preferably between 10 
and 30 micrometers. The superficial pores of this hydro gel 
substrate can vary in size by less than 50%, preferably less 
than 30%, and preferably less than 10%. The hydrogel sub-
strate of the present invention can be made up of polyvinyl 
alcohol and can have a water content of at least 5% w/w of the 
overall hydrogel. The hydro gel substrate of the present inven-
tion could be used in any load bearing implantable device 
application including, but not limited to, a spinal disc replace-
ment. The present invention when used as a spinal disc 
replacement can possess the surface pores in the proper con- 15 
figuration and be additionally comprised of multiple regions 
10 sand, silicon, silica, and ultra-fine particulate matter. The 
solid objects used to create the superficial pores and therefore 
the pores themselves can have a diameter of between 1 and 
100 micrometers, preferably between 5 and 50 micrometers, 
and preferably between 10 and 30 micrometers. 
The solid objects used to create the superficial pores ofthis 
invention can be removed for example by use of an organic 
solvent or other washing means. This hydrogel substrate can 
be comprised of poly-vinyl alcohol possessing a water con-
tent of at least 5% w /w of the overall hydro gel. 
of varying elasticities. It is also possible that the regions of 
varying elasticities of the spinal disc replacement be com-
prised of multiple hydrogels as opposed to one hydrogel of 
varying elasticities. 
The present invention also includes a method for making a 
hydrogel substrate with a textured surface for use in a load 
bearing biocompatible device. The hydro gel in liquid form is 
exposed to solid objects or to a mold which when polymer-
ized or hardened results in a hydro gel with a textured surface. 
The solid objects used to impart the superficial pores may be 
made of polystyrene beads. Also, the solid objects used to 
impart the superficial pores may be grit, sand, silicon, silica, 
and ultra-fine particulate matter. The solid objects used to 
create the superficial pores can have a diameter of between 1 
and 100 micrometers, preferably between 5 and 50 microme-
ters, and preferably between 10 and 30 micrometers. The 
solid objects used to create the superficial pores of this inven-
tion can be removed, for example, by use of an organic sol-
vent or other washing means. This hydrogel substrate can be 
comprised of poly-vinyl alcohol possessing a water content of 
at least 5% w/w of the overall hydrogel. 
BRIEF DESCRIPTION OF DRAWINGS 
FIG. 1 is an elevation view of spinal disc replacement made 
in accordance with one embodiment of the present invention. 
FIG. 2 is a schematic of a surface generated in accordance 
with one embodiment of the present invention. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention is drawn to an implantable hydro gel 
substrate comprising a hydrogel surface having a plurality of 
superficial pores thereon. The pores on this hydrogel sub-
strate can have an average diameter of between 1 and 100 
micrometers. Preferably the average diameter of surface 
pores on the this hydrogel substrate is between 5 and 50 
micrometers, and preferably between 10 and 30 micrometers. 
The superficial pores of this hydro gel substrate can vary in 
size by less than 50%, preferably less than 30%, and prefer-
ably by less than 10%. The hydro gel substrate of the present 
invention can be made up of polyvinyl alcohol and can have a 
water content of at least 5% w/w of the overall hydrogel. 
One embodiment of the present invention is an artificial 
disc for implantation into the spine comprising the hydrogel 
substrate described above. This artificial disc is a hydrogel 
possessing a plurality of regions having variable elasticity. 
Specifically, the disc is comprised of a surface region having 
20 Accordingly, the present invention is directed to an 
implantable hydrogel substrate product, a method of making 
that product, and a method of using that product which sub-
stantially improves upon the limitations existing in the art. To 
achieve these and other advantages in accordance with the 
25 purpose of the invention, as embodied and broadly described 
herein, the invention includes a load bearing biocompatible 
hydro gel for medical implantation that promotes bone attach-
ment. The hydrogel substrate consists of a hydrogel surface 
component which has been optimized for implantation. This 
30 is accomplished through pores on the surface having a con-
trolled range in distribution of size. The surface pores are 
superficial and do not extend throughout the hydrogel. 
Hydrogels are materials whose state is between that of a 
solid and of a liquid. Gels consist of polymeric, i.e. long 
35 chain, molecules linked together to form a three-dimensional 
network and are embedded in a liquid medium. In the case of 
hydro gels, the liquid medium comprises water. The polymer 
backbone of hydrogels is formed by hydrophilic monomer 
units and may be neutral or ionic. Examples of neutral and 
40 hydrophilic monomer units are ethylene oxide, vinyl alcohol, 
(meth)acrylamide, N-alkylated(meth)acrylamides, N-methy-
lol(meth)acrylamide, N-vinylamides, N-vinylformamide, 
N-vinylacetamide, N-vinyl-N-methylacetamide, N-vinyl-N-
methylformamide, hydroxyalkyl(meth)acrylates such as 
45 hydroxyethylmethacrylate, vinylpyrrolidone, (meth)acrylic 
esters of polyethylene glycol monoallyl ethers, ally! ethers, of 
polyethylene glycols, and sugar units such as glucose or 
galactose. Examples of cationic hydrophilic monomer units 
are ethyleneimine (in the protonated form), diallyldimethy-
50 !ammonium chloride and trimethylammonium propyl-
methacrylamide chloride. Examples of anionic monomer 
units are (meth)acrylic acid, crotonic acid, maleic acid, 
fumaric acid, itaconic acid, 2-acrylamido-2-methylpropane-
sulfonic acid, vinylsulfonic acid, vinylphosphonic acid, 
55 2-methacryloyloxyethanesulfonic acid, 4-vinylbenzene-
sulfonic acid, allylsulfonic acid, vinyltoluenesulfonic acid 
and vinylbenzenephosphonic acid. 
From the example listing above, a hydrogel for use in the 
present invention may be selected based upon its biocompat-
60 ibility and stability at various hydration states. For the pur-
poses of the present invention, a suitable hydro gel will have a 
moisture content of at least 5% w/w of the overall hydrogel, 
preferably at least 10%, 15%, 20%, 25%, 30%, 35%, 40%, 
50%, 60%, 70%, or 80% w/w of the overall hydrogel. 
a higher modulus of elasticity than an interior region. This 65 
disc can be prepared using multiple hydro gels with the elastic 
properties of the one disc with varying regions of elasticity. 
Initial events following implantation of a biomaterial in an 
orthotopic surgical site include rapid adsorption of serum 
constituents onto the implant surface. The first cells that are 
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likely to come into contact with the surface are polymorpho-
nuclear cells, platelets, monocytes, and macrophages. These 
cells release bioactive factors that promote mesenchymal cell 
migration to the wound site. In addition to these natural 
factors associated with wound healing, surgeons frequently 
use bone graft and bone graft substitutes to improve bone 
formation. Such materials include osteoinductive agents such 
as demineralized bone matrix and bone morphogenetic pro-
tein. If appropriate signals are present mesenchymal cells 
with an osteoprogenitor phenotype will continue to differen- 10 
tiate into osteoblasts; of these a subset will become osteo-
cytes. Ultimately, the newly formed bone will be remodeled 
via osteoclastic resorption. The present invention also pro-
vides that well-known grafting agents may be incorporated 15 
into the hydrogel composition, which includes, but is not 
limited to growth factors, angiogenic agents, antibiotics, and 
the like. 
6 
gel is preferably less than 1 millimeter, less than 500 
micrometers, and most preferable less than or equal to 200 
micrometers. 
The hydrogel substrates of the present invention can be 
used for implantation into any part of the body. One embodi-
ment of this invention is an artificial intervertebral disc, com-
prising one or more hydrogels shaped substantially similarly 
to a natural intervertebral disc. The upper and lower surfaces 
of the hydrogel, or assembly ofhydrogels, are constructed to 
have a rouges or textured surface with a defined porosity. That 
porosity depends primarily upon the size of a solid object 
used to create the surface texture. The surface texture is cre-
ated by the distribution of pores that do not continue through-
out the hydrogel, or, in other words, the pores are superficial. 
The size of the pores can be from 2 to 100 micrometers, 
preferably from 5 to 50 micrometers, and preferably, from 10 
to 30 micrometers. 
The porosity of the hydrogel surface embodied in this 
invention may be realized in a variety of ways. Molds may be Chemically modified or polar surfaces are generally 
known to be able to produce more reactive protein adsorption 
to the implant surface than unmodified or non-polar surfaces. 
The increased reactivity of the proteins adsorbed onto the 
polar surface is thought to promote cellular adhesion to that 
surface. Therefore, the invention provides that the hydrogel 
composition can possess chemically modified or polar sur-
faces. 
20 constructed with patterning on the appropriate surfaces of the 
cavities in the mold. Alternatively, the porosity may be pro-
duced by abrasion of a smooth hydrogel surface after mold-
ing. Abrading the surface with grit will result in a surface 
textured such as desired in this invention. Techniques for 
25 applying and using abrasives are well known to those of skill 
in the art. 
In general, many materials are well-tolerated in bone, but 
the success of long-term or chronic implantation often 
depends on the intimacy of the interface between the material 
surface and the bone. Microarchitecture of the surface is an 30 
important determinant of cell response. It has been observed 
that osteoblast phenotypic expression is surface-dependent. 
One technique for producing the surface roughness of arti-
ficial discs of this invention involves providing solid objects 
having the size and shape of the required surface rugosity and 
then using these solid objects as a template for the construc-
tion of a mold. Alternatively, these solid objects may be 
embedded in the hydro gels of the present invention during the 
molding process and removed afterwards. Removal of the 
solid objects leaves behind on the surface of the hydrogel 
As described herein, specific surface characteristics enhance 
osteoblast differentiation while permitting proliferation, 
leading to optimal cell response to the implantation. 35 pores, cavities, and other invaginations required for the tex-
ture of the surface to be obtained. The mechanical properties of the material must be appro-
priate for the application. When the mechanical properties of 
the material are similar to the mechanical properties of the 
tissue adjacent to the implant, tissue tolerance of the artificial 
material is enhanced. Polymeric and elastomeric biomaterials 40 
can be fabricated with a wide range of mechanical properties, 
making them suitable for many applications as implantable 
devices. Because of their high water content, similar to that of 
living tissue, hydrogels are superior in biocompatibility to 
non-hydrous polymeric materials. Poly-vinyl alcohol (PVA) 45 
is an example ofa polymer that can be used to formhydrogels, 
and has been studied extensively for its potential in biomedi-
One example of a material that can be used as solid objects 
to impart the surface texture on the hydrogels of the present 
invention is polystyrene. Polystyrene beads, commonly 
called latex beads, are commercially available in sizes rang-
ing from 0.02 to 1000 micrometers, and can have a very 
narrow size distribution. Such a narrow size distribution is 
advantageous for applications requiring uniform surface 
roughness. For example, when using polystyrene beads with 
an average diameter of 20.3 µm an acceptable range for the 
distribution of bead size would be .+-.0.6 µm, preferably 
.+-.0.5 µm, and preferably .+-.0.4 µm. Polystyrene beads 
may be obtained having surface functional groups useful for 
covalent chemical attachment of various chemical entities to 
cal applications. Poly-vinyl alcohol hydrogels (PVA-Hs) are 
biologically well tolerated and compatible with living carti-
lage tissue. 50 the surface of the beads. Polystyrene beads may also be 
obtained either crosslinked or uncrosslinked. The latter type 
of beads are insoluble in water, but freely soluble in many 
organic solvents. Thus, one method for removal of the beads 
PVA-Hs can be produced from solution via repeated freez-
ing and thawing cycles that increase the order of the microc-
rystalline regions, changing the dissolution properties, mesh 
size, and diffusion properties of the polymer. Also, PVA-Hs 
can be produced from solution via a slow and sustained tran- 55 
sition through the freezing point of the solution. The 
mechanical properties of PVA-Hs can be varied over a wide 
range, and stable PVA gels can easily be produced to have an 
elastic modulus ranging from a few MPa, such as articular 
cartilage, to about 50 MPa, such as the stiffest portion of the 60 
annulus of spinal discs. 
Increasing the porosity of a hydrogel substrate produces 
decreased mechanical strength. When porous hydrogels are 
used to provide the requisite surface of the present invention, 
it is advantageous that the porosity not extend throughout the 65 
hydrogel, but be limited to a relatively shallow depth below 
the surface. The thickness of the porous portion of the hydro-
after the molding process is the dissolution of the beads in 
appropriate organic solvents. 
The pores on the textured surface in this embodiment 
enable the surface to resemble native bone which has under-
gone osteoclastic resorption. When surface textured hydro-
gels are used to provide the requisite surface porosity, it is 
advantageous for the pores not to extend throughout the 
hydrogel, but instead be limited to a relatively shallow depth 
below the textured surface. The thickness of the porous por-
tion of the hydro gel surface is preferably less than 1 millime-
ter, preferably less than or equal to 500 micrometers, and 
preferably less than or equal to about 200 micrometers. 
The hydro gels of the present invention may contain bioac-
tive factors to further stimulate cell growth or differentiation. 
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These factors, for instance attachment peptides, such as RGD 
containing peptides, and growth factors such as bone mor-
phogenic proteins, insulin-like growth factor, platelet derived 
growth factor, fibroblast growth factor, cartilage-derived 
growth factor, transforming growth factor-beta, and parathy-
roid hormone related peptide, as well as other regulatory 
chemicals such as statins, prostaglandins, and mineral ions 
well-known in the art. These factors may be included in the 
hydrogels of this invention singly or in combination, and they 
may be included with or without binding proteins. 
The hydro gels of the present invention may also contain 
bone or cartilage forming cells ( osteoblasts or chondrocytes) 
or precursor cells to bone and cartilage forming cells such as 
mesenchymal stem cells or osteoprogenitor cells. These pre-
cursor cells have the capacity to differentiate into bone and/or 15 
cartilage forming cells. Cells may be included in the hydro-
gels of the present invention alone or in combination with 
bioactive factors to further stimulate cell growth or differen-
tiation. 
appropriate surfaces of the mold prior to crosslinking of the 
hydrogel. After crosslinking, the polystyrene beads are 
removed by dissolving them in a solvent such as dimethyl 
formamide or its equivalent that does not dissolve the hydro-
gel. Such treatment produces porosity and surface roughness 
with dimensions approximately equal to the diameter of the 
polystyrene beads. The invaginations left behind after 
removal of the polystyrene beads contribute to the controlled 
surface texture desired in the present invention. The polysty-
lO rene beads of this embodiment may also be adhered to a 
surface and used as a part of a mold, or as a template in the 
construction of a mold. 
Natural intervertebral discs have a tough outer fibrocarti- 20 
laginous ring called the annulus fibrosus and a soft, inner, 
highly elastic structure called the nucleus pulpous. The arti-
ficial discs of the present invention may contain an inner core 
constructed to mimic the physical and mechanical properties 
of the natural nucleus pulpous, surrounded by an annular 25 
region constructed to mimic the physical and mechanical 
properties of the natural annulus fibrosus. 
In one embodiment, these regions comprise hydrogels 
whose water content, degree of polymerization, and degree of 
crosslinking are adjusted to produce the requisite physical 30 
and mechanical properties. The hydrogel comprising the 
inner core has a higher water content and/or a lower degree of 
polymerization and/or a lower degree of crosslinking to pro-
duce a relatively soft and elastic hydrogel. The hydrogel 
comprising the outer annular region has a lower water content 35 
and/or a higher degree of polymerization and/or crosslinking 
to produce a relatively hard outer hydrogel which mechani-
cally is tough and stiff. The hydrogels comprising the upper 
and lower surfaces may substantially resemble the hydrogel 
comprising the annular region in terms of physical and 40 
mechanical properties, water content, and degrees of 
crosslinking and polymerization. The additional requirement, 
however, for the surfaces to be porous may allow or require a 
different combination of physical and mechanical properties 
in these hydrogels compared to the hydrogel comprising the 45 
outer annular region. 
FIG. 1 shows a spinal disc replacement envisioned by the 
present invention. The spinal disc has an upper portion 1 and 
a lower portion 2. It is the hydrogel substrate surfaces of the 
upper portion 1 and lower portion 2 which possess the porous 50 
texture of the present invention. The upper portion 1 and 
lower portion 2 can be less elastic and more rigid than the 
inner region 4 which seeks to mimic the nucleus pulpous. 
Likewise, the spinal disc may have an intermediate region of 
elasticity 3 which further aids in the function of the spinal 55 
disc. The intermediate region of elasticity 3 may or may not 
differ from the elasticity of either the inner region 4 or the 
upper portion 1 or lower portion 2. 
FIG. 2 shows the upper portion 1 of the spinal disc of FIG. 
1 possessing superficial surface pores 10 of the present inven- 60 
ti on. The sizing of these pores as described herein promotes 
differentiation of cells into desired tissues, such as bone or 
bone-like cells, and induces the attachment of those cells to 
the surface. 
In another embodiment of this invention, the solid object 
used in the casting of a rough hydro gel surface is grit. Grit can 
be any solid object that is small with a narrow size distribu-
tion. Examples of grit include sand, silica particles, silicone 
particles, metal shot, etc. Those skilled in the art would rec-
ognize the need to match the grit used to the hydrogel along 
with the method of removing the grit leaving the rough or 
porous surface. 
A silica grit of appropriate size can be used to impart the 
proper level of porosity on the surface of a hydro gel. As was 
seen with the polystyrene, the sand is placed in the bottom of 
a mold and the aqueous hydro gel is poured into the mold. The 
hydrogel is allowed to crosslink and polymerize and is then 
removed from the mold. The hydrogel is then washed to 
remove the grit leaving behind the invaginations and pores 
which make up the textured surface of the hydro gel implant. 
Grit may also be adhered to a surface and used as a part of a 
mold, or as a template in the construction of a mold. 
In yet another embodiment of the present invention, the 
mold used in the formation of the hydrogel substrate can be 
any type of material around which the hydrogel forms. For 
example, the mold can be a series of beads, grit, filter screens, 
mesh, wires, glass tubing, and the equivalents of these mate-
rials or items. Once the hydrogel has been allowed to form 
around the mold element, the mold is removed from the 
hydrogel manually, chemically, or any other means which 
will allow the hydrogel to remain intact once the mold has 
been removed. 
In yet another embodiment of the present invention, the 
hydrogel substrate can be a load bearing patch which can be 
used in the repair of partially or predominately damaged 
tissue. For example, the hydrogel substrate bearing the tex-
tured surface of the present invention can be relatively thin 
and small in diameter. That hydrogel substrate can then be 
placed where deteriorated, either acutely or chronically, car-
tilage was removed. 
In yet another embodiment of the present invention, the 
hydrogel substrate can be assembled outside the body in a 
malleable form. The malleable form of the hydro gel substrate 
can then be placed in the intended area, be it a spinal disc 
replacement, knee cartilage replacement, shoulder bursa 
repair, or other use one skilled in the art would foresee. Once 
in the proper position, the malleable hydrogel substrate could 
be hardened or polymerized via photopolymerization. Radia-
tion curing or photopolymerization (photo-induced free radi-
cal polymerization) has become an important and useful tech-
nique for applying and curing coatings, inks and adhesives. 
Radiation-curable compositions typically comprise as essen-
tial components one or more radiation-curable monomers and 
a photoinitiator. The compositions are applied as a coating to 
various articles and surfaces and the monomers are polymer-
In one embodiment, the superficial pores can be created 
with solid polystyrene beads of20.7 µm to 19.9 µm of average 
diameter suspended in the hydrogel solution, or coated on the 
65 ized to form a film by exposing the coating of the radiation-
curable composition to radiation, typically ultraviolet (UV) 
or electron-beam radiation. 
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EXAMPLES 
Example 1 
Attachment of Polystyrene Objects to a Surface 
10 
suspension to coat the surfaces of the mold cavities to a 
thickness of 200 µm. Inserts are placed in each cavity to 
spread the suspension across the surfaces of the cavities and 
maintain the 200 µm thickness. 
The two halves of the mold are then subjected to five cycles 
of freezing and thawing. In each cycle, the molds are placed 
in a freezer at about -20° C. for approximately 12 hours then 
removed from the freezer and placed at room temperature for 
approximately 12 hours. The inserts defining the first 200 µm 
To a suspension of carboxyl-modified polystyrene beads 
(20.3 µm.+-.0.43 µm diameter, Bangs Laboratories) in 20 nM 
MEW, pH 4.4 is added a 10-fold excess of water-soluble 
carbodiimide, 1-ethy 1-3-( d-dimethylaminopropy 1) carbodi-
imide hydrochloride. After 15 minutes at room temperature, 
the beads are washed twice by centrifugation and suspension 
10 thickness of the top portion of the upper surface and the 
bottom portion of the lower surface are removed from the 
molds, and an additional amount of the 30% poly( vinyl alco-
hol) solution (without polystyrene objects) is added to the 
mold cavities. The amount added is sufficient to increase the 
in 20 mM HEPES, pH 7 .5 and then resuspended in the same 
buffer. The resulting suspension is added to the wells of a 
24-well tissue culture plate made of polycarbonate, having an 
amino-modified surface (Nalge Nurre International). After 60 
minutes at room temperature, the unreacted beads are 
decanted, and the wells are washed gently with deionized 
water. Microscopic analysis shows the bottom surface of the 
wells are covered with a mono layer of polystyrene beads at a 20 
density of approximately 50%. 
15 thickness of the top portion of the upper surface and the 
bottom portion of the lower surface to 1 mm. Inserts are 
placed in each cavity to spread the solution and maintain the 
1 mm thickness. 
The surface with attached polystyrene objects of the pre-
vious example may be used as a template to fabricate a mold 
for providing the desired porous surface of the hydro gels of 
the present invention. This may be accomplished by making 25 
a metallic replica of a surface comprising a plurality of poly-
styrene objects using sputtering and/or metal plating tech-
niques and the like, all of which are well known to those of 
skill in the art. The metallic replica thus produced may be 
replicated again and reinforced with further metal or other 30 
components, again using methods well known to those skilled 
in the art. The result is a mold suitable for producing the 
surface texture of the hydrogels of the present invention. 
The polystyrene objects of the foregoing example may also 
be included in the hydro gels of the present invention during 35 
the molding process. Subsequent removal of the polystyrene 
objects provides the controlled surface porosity provided for 
the hydro gels of the present invention. This is illustrated in the 
following example. 
The two halves of the mold are subjected to five additional 
cycles of freezing and thawing as above. The inserts defining 
the top portion of the upper surface and the bottom portion of 
the lower surface are removed from the molds, and annular 
inserts defining the shape of the core region are placed in the 
cavities of the lower half of the mold. A 20% w/w poly( vinyl 
alcohol) solution is prepared by mixing poly(vinyl alcohol) 
polymer (89,000-98,000 Av. MW 99+% saponification, Ald-
rich Chemical Company) in sterile, deionized water and dis-
solving as above. The solution is filled into the annular inserts 
and the mold is subjected to five additional cycles of freezing 
and thawing. The annular inserts are removed, the two halves 
of the mold are assembled and clamped together, and the 
areas of the mold corresponding the annular region are filled 
with 30% poly( vinyl alcohol) solution. The assembled mold 
is subjected to five more cycles of freezing and thawing. The 
molded artificial discs are removed from the mold and 
immersed in dimethyl formamide to dissolve the included 
polystyrene objects, the rinsed three times with deionized 
water. 
The artificial disc produced by the forgoing example has a 
Example 2 
Construction of a PVA-H with Surface Topography 
for Implantation as a Spinal Disc Prosthesis 
40 soft and elastic inner core while the outer annular region and 
upper and lower surfaces are relatively hard, tough, and stiff. 
The surface of the artificial disc is smooth, except on the top 
portion of the upper surface and the bottom portion of the 
lower surface where the removal of the polystyrene objects 
45 produces a rough or rugose surface with a roughness of 20 
µm. When artificial discs made according to this procedure 
are implanted into the intervertebral spaces of disectomized 
rabbits, extensive bone growth onto the surface occurs within 
3 weeks. 
A two-part mold with inserts is used to produce the artifi-
cial disc depicted in FIG. 1. The upper and lower halves of the 
mold are first separated to mold the upper and lower surface 
regions of the disc. The surface of each corresponding upper 
and lower surface is created by suspending in the aqueous 50 
hydrogel the objects for creating the superficial pores. That 
suspension is then poured into the well of a mold at a depth no 
greater than the desired depth of the superficial pores. That 
layer of hydrogel is allowed to polymerize and crosslink. 
From that base layer creating the outermost layer of the cor- 55 
responding surface, the remainder of the bulk of the hydro gel 
substrate can be built up by adding additional depth of aque-
ous hydrogel. 
A 30% w/w poly(vinyl alcohol) solution is prepared by 
mixing poly(vinyl alcohol) polymer (124,000-186,000 Av. 60 
MW, 99+% saponification, Aldrich Chemical Company) in 
sterile, deionized water. The polymer is dissolved by heating 
the mixture in an autoclave at 120° C. for 30 minutes. To a 
portion of the viscous liquid solution is added 30% w/w of the 
polystyrene objects from Example 1. This is mixed until a 65 
uniform suspension is obtained. To each of the cavities in 
each half of the mold is added a sufficient amount of this 
Although the invention has been described with reference 
to a particular preferred embodiment with its constituent 
parts, features and the like, these are not intended to exhaust 
all possible arrangements, mechanical and electrical equiva-
lents, or features, and indeed many other modifications and 
variations will be ascertainable to those of skill in the art. 
What is claimed is: 
1. A biocompatible hydrogel configured for implantation 
into a joint, comprising: 
a top surface configured for attachment to a patient's native 
tissue; 
a bottom surface generally opposite of the top surface; 
a depth defined between the top surface and the bottom 
surface; 
superficial pores located within about 1 millimeter of the 
top surface of the hydrogel; 
wherein the superficial pores do not extend throughout an 
entire depth of the hydrogel; 
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wherein said superficial pores enhance osteoblast differen-
tiation and permit proliferation of osteoblasts· and 
wherein the hydrogel is load-bearing. ' 
2. The biocompatible hydrogel of claim 1, wherein the 
hydrogel is configured for implantation into at least one of a 5 
knee, shoulder or spine. 
3. The biocompatible hydrogel of claim 1, wherein the 
pores have an average cross-section of between about 1 to 100 
micrometers. 
4. The biocompatible hydrogel of claim 1, wherein the 10 
pores have an average cross-section of between about 10 to 30 
micrometers. 
5. The biocompatible hydrogel of claim 1, wherein the 
pores are within about 200 micrometers of the surface of the 
hydrogel. 15 
6. The biocompatible hydrogel of claim 1, wherein the 
hydrogel comprises polyvinyl alcohol. 
7. The biocompatible hydrogel of claim 1, wherein the 
hydrogel has a moisture content of at least 5% w/w of the 
overall hydrogel. 20 
8. The biocompatible hydrogel of claim 1, wherein the 
hydrogel has a moisture content of at least 30% w/w of the 
overall hydrogel. 
9. The biocompatible hydrogel of claim 1, wherein the 
hydrogel comprises a chemically-modified or polar surface to 25 
promote cellular adhesion. 
10. A load bearing hydrogel implant comprising: 
a first surface having a plurality of superficial pores 
thereon, said first surface being configured for attach-
ment to a patient's native joint tissue; 30 
wherein said superficial pores are located at or near the first 
surface; 
12 
wherein said superficial pores do not extend throughout 
said hydrogel; 
wherein the hydrogel is configured for implantation into a 
joint; 
wherein the superficial pores have an average cross-section 
of between about 1and100 micrometers· and 
wherein the pores are within about 1 millimeter of the 
hydrogel surface. 
11. The hydrogel implant of claim 10, wherein the hydro-
gel is configured for implantation into at least one of a knee 
shoulder or spine. ' 
12. The hydrogel implant of claim 10, wherein the pores 
have an average cross-section of between about 1 to 100 
micrometers. 
13. The hydrogel implant of claim 10, wherein the pores 
have an average cross-section of between about 1 O to 30 
micrometers. 
14. The hydrogel implant of claim 10, wherein the pores 
are within about 1 millimeter of the surface of the hydrogel. 
15. The hydrogel implant of claim 10, wherein the pores 
are within about 200 micrometers of the surface of the hydro-
gel. 
16. The hydrogel implant of claim 10, wherein the hydro-
gel comprises polyvinyl alcohol. 
17. The hydro gel implant of claim 10, wherein the hydro-
gel has a moisture content of at least 5% w/w of the overall 
hydro gel. 
18. The hydrogel implant of claim 10, wherein the hydro-
gel has a moisture content of at least 30% w/w of the overall 
hydro gel. 
* * * * * 
